Parkinson'
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with PDD or DLB who are attending or being admitted to the Department of Neurology, Juntendo University Hospital, Juntendo University School of Medicine, will be included in the study. PDD is diagnosed as Clinically Established PD or Clinically Probable PD by MDS Clinical Diagnostic Criteria for Parkinson's Disease, and PDD is defined as the onset of Dementia 2 years later. DLB is defined as patients diagnosed with Probable DLB (almost certain) by the Clinical Diagnostic Criteria for Dementia with Lewy Bodies (2017) Amyloid PET and neuropsychological testing can be performed For whom 123I-Ioflupane SPECT testing has been performed IMP-SPECT test performed has been performed
Exclusion criteria
Exclusion criteria: Age less than 40 years and greater than 81 years at the time consent was obtained Patients with more than moderate multiple cerebral infarctions Those with a history of epileptic seizures within 2 years Other subjects deemed inappropriate as research subjects by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| beta-amyloid deposition in the brain | — |
Countries
Japan
Contacts
Juntendo University School of Medicine Department of Neurology